tiprankstipranks
Dermapharm Holding SE (DE:DMP)
XETRA:DMP
Germany Market
DMP
Dermapharm Holding SE
RESEARCH TOOLSreports

Dermapharm Holding SE (DMP) Financial Statements

12 Followers

Dermapharm Holding SE Financial Overview

Dermapharm Holding SE's market cap is currently €2.37B. The company's EPS TTM is €0.69; its P/E ratio is 14.36; and it has a dividend yield of 2.34%. Dermapharm Holding SE is scheduled to report earnings on March 10, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Mar 22
Income Statement
Total Revenue€ 1.16B€ 1.18B€ 1.14B€ 1.02B€ 942.91M
Gross Profit€ 391.71M€ 767.07M€ 719.16M€ 660.83M€ 620.69M
Operating Income€ 221.75M€ 216.93M€ 182.89M€ 243.69M€ 298.47M
EBITDA€ 314.31M€ 320.91M€ 265.55M€ 329.81M€ 358.10M
Net Income€ 132.41M€ 113.79M€ 62.37M€ 134.24M€ 209.58M
Balance Sheet
Cash & Short-Term Investments€ 203.41M€ 121.71M€ 159.54M€ 161.36M€ 172.06M
Total Assets€ 2.20B€ 2.08B€ 2.16B€ 1.41B€ 1.41B
Total Debt€ 1.05B€ 979.61M€ 1.08B€ 516.45M€ 580.30M
Net Debt€ 848.88M€ 858.42M€ 921.66M€ 366.53M€ 419.98M
Total Liabilities€ 1.50B€ 1.47B€ 1.62B€ 880.34M€ 907.13M
Stockholders' Equity€ 694.38M€ 604.42M€ 539.21M€ 531.59M€ 497.32M
Cash Flow
Free Cash Flow€ 139.39M€ 163.14M€ 177.88M€ 249.52M€ 189.16M
Operating Cash Flow€ 181.51M€ 201.38M€ 219.42M€ 288.53M€ 250.37M
Investing Cash Flow€ -110.03M€ -29.61M€ -415.43M€ -99.01M€ -129.35M
Financing Cash Flow€ 13.32M€ -209.17M€ 204.54M€ -199.77M€ -80.98M
Currency in EUR

Dermapharm Holding SE Earnings and Revenue History

Income Statement >

Dermapharm Holding SE Debt to Assets

Balance Sheet >

Dermapharm Holding SE Cash Flow

Cash Flow >

Dermapharm Holding SE Forecast EPS vs Actual EPS

Earnings >